openPR Logo
Press release

Controlled Release Drug Delivery Market Poised for 7.8% CAGR Growth During Forecast Period 2022 to 2029

09-15-2023 11:18 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Controlled Release Drug Delivery Market Poised for 7.8% CAGR

In a recently released analysis titled "Controlled Release Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2029," Exactitude Consultancy, a reputable market research firm, provided data. The report offers a thorough overview of the market, including data on market size, trends, and growth projections for the global Controlled Release Drug Delivery market. The study highlights the most recent developments in the industry and provides competitor and geographical analysis.

"The global controlled release drug delivery market size is expected to grow at 7.8% CAGR from 2022 to 2029. It is expected to reach above USD 78.41 billion by 2029 from USD 39.88 billion in 2020."

Request for a free sample copy of this report-> https://exactitudeconsultancy.com/reports/3477/controlled-release-drug-delivery-market/#request-a-sample

**Note - Updated Version 2023 is available

►What this report provides?

» The research provides a comprehensive overview of the current state of the Controlled Release Drug Delivery market and its anticipated future evolution.

» Key companies manufacturing Controlled Release Drug Delivery worldwide are profiled, providing an overview of their financials, product portfolio, recent developments, and future outlook.

» The report evaluates the current opportunity and future growth potential of the Controlled Release Drug Delivery market, providing estimates for its mid-to-long term evolution during the forecast period 2023-2029, aiming to identify potential trends and opportunities.

» Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-over-year growth, competitive benchmarking, vendor identification, CMI quadrant, and other significant analysis, as well as development status.

» Recent market trends and its potential for future growth
regional reports that can be customised upon request

►Who are the major players in this industry?

Orbis Biosciences, Inc., Merck and Co., Inc., Alkermes plc, Johnson and Johnson, Coating Place, Inc., Corium International, Inc., Depomed, Inc., Pfizer, Inc, Aradigm Corporation, Capsugel, and others.

► Recent Developments in Controlled Release Drug Delivery Market

Recent developments in Controlled Release Drug Delivery industry, even after market report release, support market trends outlined in analysis.

June 2022: A research study was conducted at the University of Michigan that demonstrated a new method of drug microencapsulation, allowing several peptide drugs to be slowly released into the body.

March 2022: Evonik launched Eudratec SoluFlow, a new microparticle technology to enhance the solubility of active pharmaceutical ingredients in oral drug products. As more than 70% of new small molecules are insoluble, Eudratec SoluFlow enables the development of new oral therapeutics in diverse areas, such as cancer, cardiovascular diseases, infectious diseases, and diabetes.

► What exactly does market segmentation cover?

Global Controlled Release Drug Delivery Technology Market by Technology Outlook, 2020-2029, (USD Million) (Thousand Units)

» Wurster Technique

» Coacervation

» Micro Encapsulation

» Implants

» Transdermal

»Targeted Delivery

» Others

Global Controlled Release Drug Delivery Technology Market by Application, 2020-2029, (USD Million) (Thousand Units)

» Metered Dose Inhalers

» Injectable

» Transdermal And Ocular Patches

» Infusion Pumps

» Oral Controlled-Drug Delivery Systems

» Drug Eluting Stents

Global Controlled Release Drug Delivery Technology Market by Region, 2020-2029, (USD Million) (Thousand Units)

» North America

» Europe

» Asia Pacific

» South America

» Middle East And Africa

Important Countries In All Regions Are Covered.

► Regional Analysis of the Controlled Release Drug Delivery Market

The market development, current market trends, and some research methodologies are all covered in the Controlled Release Drug Delivery Industry research report. It draws attention to crucial aspects like product portfolios, software architectures, and production strategies that have a direct impact on the market. Our research shows that even minor changes to a product's qualities can have a big impact on the previously mentioned criteria.

►Table of Content:

1 Study Reporting
1.1 Controlled Release Drug Delivery Product
1.2 Key Segments in This Study
1.3 Key Companies Covered
1.4 Market by Type
1.4.1 Global Controlled Release Drug Delivery Market Size Growth Rate by Type
1.5 Market by Application

2 Executive Instantaneous
2.1 Global Controlled Release Drug Delivery Market Size
2.1.1 Global Controlled Release Drug Delivery Revenue
2.1.2 Global Controlled Release Drug Delivery Production
2.2 Controlled Release Drug Delivery Growth Rate (CAGR)
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio
2.3.2 Key Controlled Release Drug Delivery Manufacturers
2.3.2.1 Controlled Release Drug Delivery Manufacturing Base Distribution, Headquarters
2.3.2.2 Manufacturers Controlled Release Drug Delivery Product Offered
2.3.2.3 Date of Manufacturers Enter into Controlled Release Drug Delivery Market
2.4 Key Trends for Controlled Release Drug Delivery Markets & Products

3 Market Size by Manufacturers
3.1 Controlled Release Drug Delivery Production by Manufacturers
3.2 Mergers & Acquisitions, Expansion Plans

4 Controlled Release Drug Delivery Production by Regions

4.1 Global Controlled Release Drug Delivery Production by Regions
4.1.1 Global Controlled Release Drug Delivery Production Market Share by Regions
4.1.2 Global Controlled Release Drug Delivery Revenue Market Share by Regions
4.2 United States
4.2.1 United States Controlled Release Drug Delivery Production
4.2.2 United States Controlled Release Drug Delivery Revenue
4.2.3 Key Players in United States
4.2.4 United States Controlled Release Drug Delivery Import & Export
4.3 Europe
4.3.1 Europe Controlled Release Drug Delivery Production
4.3.2 Europe Controlled Release Drug Delivery Revenue

5 Controlled Release Drug Delivery Consumption by Regions

5.1 Global Controlled Release Drug Delivery Consumption by Regions
5.1.1 Consumption by Regions
5.1.2 Consumption Market Share by Regions
5.2 North America
5.2.1 North America Consumption by Application
5.2.2 North America Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe Consumption by Application
5.3.2 Europe Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Consumption by Application
5.4.2 Asia Pacific Consumption by Countries
5.5.1 Central & South America) Consumption by Application
5.5.2 Central & South America Consumption by Country

6 Market Size by Type
6.1 Production by Type
6.2 Revenue by Type
6.3 Price by Type

7 Market Size by Application
7.1 Overview
7.2 Global Controlled Release Drug Delivery Breakdown Dada by Application
7.2.1 Global Controlled Release Drug Delivery Consumption by Application
7.2.2 Global Controlled Release Drug Delivery Consumption Market Share by Application

8 Manufacturers Profiles
9 Production Forecasts
9.1 Controlled Release Drug Delivery Production and Revenue Forecast
9.1.1 Global Controlled Release Drug Delivery Production Forecast
9.1.2 Global Controlled Release Drug Delivery Revenue Forecast
9.2 Controlled Release Drug Delivery Production and Revenue Forecast by Regions
9.2.1 Global Controlled Release Drug Delivery Revenue Forecast by Regions
9.2.2 Global Controlled Release Drug Delivery Production Forecast by Regions
9.3 Controlled Release Drug Delivery Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Controlled Release Drug Delivery Production Forecast by Type
9.4.2 Global Controlled Release Drug Delivery Revenue Forecast by Type

10 Consumption Forecast
10.1 Controlled Release Drug Delivery Consumption Forecast by Application
10.2 Controlled Release Drug Delivery Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Controlled Release Drug Delivery Consumption Forecast by Regions
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Controlled Release Drug Delivery Consumption Forecast by Regions
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Controlled Release Drug Delivery Consumption Forecast by Regions
10.5.2 China
10.5.3 Japan
10.5.4 South Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Controlled Release Drug Delivery Consumption Forecast by Regions
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Controlled Release Drug Delivery Consumption Forecast by Regions
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Controlled Release Drug Delivery Sales Channels
11.2.2 Controlled Release Drug Delivery Distributors
11.3 Controlled Release Drug Delivery Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Key Findings in the Global Controlled Release Drug Delivery Study

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Continue….

►Healthcare Trending Reports

https://www.digitaljournal.com/pr/news/xherald/hereditary-testing-market-size-to-surpass-us-10-50-billion-by-2029

https://www.digitaljournal.com/pr/news/xherald/global-gene-therapy-market-is-projected-to-reach-the-value-of-44-6-billion-by-2029

► Customization Service of the Report:

Exactitude Consultancy offers personalized reports tailored to your specific needs, with a sales team dedicated to ensuring you receive a report that meets your specific requirements.

►Research Methodology

The report is based on data analysis strategies by skilled data analysts. The research methodology involves collecting and analyzing information to provide significant market predictions. Interviews with market influencers make primary research relevant and practical. The secondary method provides a direct insight into demand and supply. Both primary and secondary data collection methods are used, along with publicly available sources like annual reports and white papers, to provide a comprehensive understanding of the market. The report offers precise data analysis and a comprehensive market tour.

Get a Sample Copy of the Controlled Release Drug Delivery Market Research Report (Use Corporate mail id for quick response)-@ https://exactitudeconsultancy.com/reports/3477/controlled-release-drug-delivery-market/#request-a-sample

► About Us

Exactitude Consultancy is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.

► Connect Us:

PHONE NUMBER +1 (704) 266-3234

EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Controlled Release Drug Delivery Market Poised for 7.8% CAGR Growth During Forecast Period 2022 to 2029 here

News-ID: 3209589 • Views:

More Releases from Exactitude Consultancy

Cell Therapy Manufacturing Market to Reach USD 28.4 Billion by 2034, Growing at 13.9% CAGR
Cell Therapy Manufacturing Market to Reach USD 28.4 Billion by 2034, Growing at …
Introduction Cell therapy has emerged as a transformative pillar of modern medicine, offering the potential to repair, replace, or regenerate damaged tissues and organs. From CAR-T cell therapies for oncology to stem cell therapies for regenerative medicine, the field is redefining treatment paradigms across oncology, neurology, cardiology, and rare diseases. As clinical pipelines expand and more therapies achieve regulatory approval, demand for efficient and scalable cell therapy manufacturing has surged. Specialized technologies
Despite safety concerns, adavosertib exhibits early antitumor activity in uterine serous carcinoma
Despite safety concerns, adavosertib exhibits early antitumor activity in uterin …
Uterine serous carcinoma (USC) is a rare but highly aggressive subtype of endometrial cancer, accounting for less than 10% of endometrial cancer cases but contributing to a disproportionately high mortality rate. It is often diagnosed at advanced stages, making it difficult to treat with conventional methods. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72873 In recent years, the treatment landscape has expanded beyond chemotherapy and surgery to include targeted therapies,
Market for Catheter-Related Bloodstream Infections: Overview, Therapies, and Important Players | Exactitude Consultancy
Market for Catheter-Related Bloodstream Infections: Overview, Therapies, and Imp …
Catheter-related bloodstream infections (CRBSIs) are among the most common and serious complications associated with intravascular catheters used in hospitals and long-term care settings. These infections can lead to prolonged hospital stays, increased healthcare costs, and higher mortality rates. With the rising use of central venous catheters, particularly among critically ill patients, oncology cases, and those requiring long-term intravenous therapy, the global demand for effective prevention and treatment solutions is growing
ADC Technology Market to Reach USD 33.7 Billion by 2034, Growing at 13.2% CAGR
ADC Technology Market to Reach USD 33.7 Billion by 2034, Growing at 13.2% CAGR
Introduction Antibody-drug conjugates (ADCs) represent one of the most innovative breakthroughs in oncology, combining the target specificity of monoclonal antibodies with the cytotoxic potency of chemotherapeutic agents. By delivering highly toxic payloads directly to cancer cells, ADCs minimize systemic toxicity and enhance therapeutic efficacy. As cancer incidence rises worldwide and the limitations of conventional chemotherapy become more evident, ADC technology is gaining momentum. With advancements in linker chemistry, payload design, and next-generation

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase